The Onychomycosis market report provides in-depth current treatment practices, emerging drugs, Onychomycosis market share of the individual therapies, current and forecasted Onychomycosis market Size from 2017 to 2030 segmented by seven major markets.
The report also provides comprehensive current Onychomycosis Treatment practice & algorithm, market drivers, market barriers and unmet medical needs to cater best of the opportunities and assessments underlying potential of Onychomycosis Market.
Onychomycosis market key facts
According to a study conducted by P. Dyanne et al, Onychomycosis occurs in 10% of the general population but is more common in older adults; the prevalence is 20% in those older than 60 years and 50% in those older than 70 years.
According to a study by R. Ted, MD, Onychomycosis occurs in both sexes but men are more likely to develop onychomycosis than women.
Request for Sample Pages:
Key benefits of Onychomycosis Market report
Onychomycosis market report provides an in-depth analysis of Onychomycosis market, size, share, trend analysis epidemiology and market forecast till 2030, in 7 major market i.e. EU5 (Germany, italy, Spain, France and the UK), Japan, and the United States.
The Onychomycosis market report covers Onychomycosis Current treatment practices, emerging drugs, market share of the individual therapies.
The Onychomycosis market report covers the marketed and emerging therapies of Onychomycosis.
The Onychomycosis market report helps businesses understand the Onychomycosis Market trends that will shape and drive the Onychomycosis market in upcoming years.
The Onychomycosis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Onychomycosis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
Onychomycosis Market segment gives a thorough detail of Onychomycosis Market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
The Onychomycosis Epidemiology division provides insights about historical and current Onychomycosis patient pool and forecasted trends for every seven major countries.
The disease epidemiology covered in the report provides historical as well as forecasted Onychomycosis Epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
The epidemiology segment also provides the Onychomycosis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan along with diagnosed patient pools and their trends with assumptions undertaken.
The launch of the emerging therapies is expected to significantly impact the Onychomycosis Treatment scenario in the upcoming years. Some of the emerging therapies in Onychomycosis market includes P3058, BB2603, ME1111, and many others.
Key players such as Moberg Pharma, Almirall, NovaBiotics, Blueberry Therapeutics and many Others are developing therapies for the treatment of patients with Onychomycosis.
Table of content
1. Key Insights
2. Executive Summary
3. Onychomycosis Competitive Intelligence Analysis
4. Onychomycosis Market Overview at a Glance
5. Onychomycosis Disease Background and Overview
6. Onychomycosis Patient Journey
7. Onychomycosis Epidemiology and Patient Population
8. Onychomycosis Treatment Algorithm, Current Treatment, and Medical Practices
9. Onychomycosis Unmet Needs
10. Key Endpoints of Onychomycosis Treatment
11. Onychomycosis Marketed Products
12. Onychomycosis Emerging Therapies
13. Onychomycosis Seven Major Market Analysis
14. Attribute analysis
15. Onychomycosis Market Outlook (in 7 major markets)
16. Access and Reimbursement Overview of Onychomycosis
17. KOL Views on the Onychomycosis market.
18. Onychomycosis Market Drivers
19. Onychomycosis Market Barriers
21. DelveInsight Capabilities
23. About DelveInsight
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States